[Pharmacology of N-propyl-ajmaline bromide (NPAB)].
D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects*; D001835:Body Weight / Q000187:drug effects; D001965:Bromides / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity*; D002339:Carotid Arteries; D002415:Cats; D003864:Depression, Chemical; D004285:Dogs; D004361:Drug Tolerance; D004562:Electrocardiography; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects*; D006329:Heart Conduction System / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects*; D007263:Infusions, Parenteral; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D051379:Mice; D008517:Phytotherapy; D010946:Plants, Medicinal; D051381:Rats; D011926:Rauwolfia / Q000008:administration & dosage / Q000494:pharmacology* / Q000633:toxicity*; D012119:Respiration / Q000187:drug effects*; D013268:Stimulation, Chemical
D000959:Antihypertensive Agents; D001965:Bromides
K farmakologii N-propil-aĭmalin bromida (NPAB)